COSCIENS Biopharma (CSCI) Q4 2024 Earnings

12NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-4.74
-3.37
-2.01
-0.64

Details

Expected EPS
-3.48
Actual EPS
-1.85
Surprise EPS
1.63
Surprise Percent
+46.84%

Description

COSCIENS Biopharma (CSCI) has reported earnings of -1.85 per share for Q4 2024.

0 Comments

Share your thoughts